Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Wilcox

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Antimicrobial Chemotherapy|April 17, 2019
Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colonC M Rooney, A E Sheppard, E Clark, et al.
Journal of Clinical Microbiology|October 29, 2010
Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infectionC W Knetsch, D Bakker, R F de Boer, et al.
The Journal of Hospital Infection|May 1, 2021
The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut modelH C Harris, A M Buckley, W Spittal, et al.
Epidemiology and Infection|October 23, 2015
Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012Á Plaza-Garrido, J Barra-Carrasco, J H Macias, et al.
Clinical and Experimental Immunology|February 19, 2017
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administrationO H Negm, B MacKenzie, M R Hamed, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 28, 2018
Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious DiseasesJ Rello, T S R van Engelen, E Alp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2018
Guidance document for prevention of Clostridium difficile infection in acute healthcare settingsS Tschudin-Sutter, E J Kuijper, A Durovic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2012
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in EnglandM H Wilcox, N Shetty, W N Fawley, et al.
The Journal of Hospital Infection|December 3, 2022
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)V F Viprey, G Granata, K E W Vendrik, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 20, 2015
Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012D W Eyre, L Tracey, B Elliott, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|April 17, 2019
Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colonC M Rooney, A E Sheppard, E Clark, et al.
Journal of Clinical Microbiology|October 29, 2010
Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infectionC W Knetsch, D Bakker, R F de Boer, et al.
The Journal of Hospital Infection|May 1, 2021
The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut modelH C Harris, A M Buckley, W Spittal, et al.
Epidemiology and Infection|October 23, 2015
Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012Á Plaza-Garrido, J Barra-Carrasco, J H Macias, et al.
Clinical and Experimental Immunology|February 19, 2017
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administrationO H Negm, B MacKenzie, M R Hamed, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 28, 2018
Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious DiseasesJ Rello, T S R van Engelen, E Alp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2018
Guidance document for prevention of Clostridium difficile infection in acute healthcare settingsS Tschudin-Sutter, E J Kuijper, A Durovic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2012
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in EnglandM H Wilcox, N Shetty, W N Fawley, et al.
The Journal of Hospital Infection|December 3, 2022
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)V F Viprey, G Granata, K E W Vendrik, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 20, 2015
Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012D W Eyre, L Tracey, B Elliott, et al.
Pageof 15